Equity Overview
Price & Market Data
Price: $0.118
Daily Change: +$0.0139 / 11.74%
Daily Range: $0.092 - $0.127
Market Cap: $13,152,380
Daily Volume: 55,477,510
Performance Metrics
1 Week: 1.50%
1 Month: -13.64%
3 Months: -78.77%
6 Months: -74.23%
1 Year: -99.17%
YTD: -99.17%
Details
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.